Multi-disciplinary Participatory Design of a Process to Deliver a CKD Diagnosis in Primary Care

Chronic Kidney Disease Clinical Trial

— EPIK  

Official title:

Multi-disciplinary Participatory Design of a Process to Deliver a CKD Diagnosis in Primary Care

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03084159
• Other study ID #: HUM00118819
• Secondary ID: 4K23DK097183-04
• Status: Completed
• Phase: N/A
• Start date: June 5, 2017
• Est. completion date: September 11, 2020

Study information

• Verified date: September 2021
• Source: University of Michigan
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will use an adapted education worksheet to support patient-centered chronic kidney disease (CKD) communication, shared decision making, and patient engagement and will test its impact on intermediate patient modifiable characteristics in a primary care practice with patients who have pre-dialysis CKD.

The study team will enroll up to 100 patients with chronic kidney disease (CKD) from a primary care clinic to start. Patients will receive the intervention, which consists of the physicians using the education worksheet during appointments with patients, and patients and providers will complete surveys about its use and to measure impact on knowledge and other areas related to patient outcomes.

Once initial user testing is complete, the study team plans to submit an amendment to expand on this trial and incorporate comparison sites. This will be submitted and receive IRB approval prior to participant involvement.

The study hypothesis is that patients who receive the intervention will have greater knowledge about their CKD diagnosis, higher satisfaction with provider communication, and higher scores related to managing CKD to keep themselves healthy compared to control populations.

Description:

Amendment on 12/2018: The enrollment numbers were updated to include the control group.

Clarification 9/2021: After initial feasibility was assessed, the initial site was used additionally to enroll for the "second arm", rather than a new site as originally intended. A second site was then used for the control population.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 78
• Est. completion date: September 11, 2020
• Est. primary completion date: September 11, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years old or older

• Have an estimated glomerular filtration rate (eGFR) of less than 60 ml/min/1.73 m2

• Able to read and understand English without an interpreter

• Diagnosed with chronic kidney disease on record

Exclusion Criteria:

• Patients with renal transplant or on dialysis

• Patients who have documented or provider known cognitive impairment or vision impairment that will prohibit meaningful interaction with education activation worksheet

• Patients who are not aware of their CKD diagnosis

Related Conditions & MeSH terms

• Chronic Kidney Disease
• Kidney Diseases
• Renal Insufficiency, Chronic

Intervention

Behavioral:
• Education worksheet
Patients who screen positive for CKD and give written informed consent to be a part of the study will have their chart flagged for the medical assistant and provider to give the education worksheet intervention. The education worksheet has been developed to be used as an electronic tool within the Electronic Medical Record. The provider will review it with the patient during the visit. A paper copy will print out for the patient at the end of the visit.

Locations

Country	Name	City	State
United States	Canton Health Center	Canton	Michigan
United States	Northville Health Center	Northville	Michigan

Sponsors (2)

Lead Sponsor	Collaborator
University of Michigan	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Level of positive assessment of care as measured by the Patient Assessment of Care for Chronic Conditions (PACIC) scale	This is a 11-item scale evaluating patient assessment of the quality of care that patients received in the past 6 months. Score range is 1-5, where 1 means poor assessment of quality of care and 5 means good assessment of quality of care.	6 months
Primary	Level of objective understanding of CKD as measured by the Kidney Knowledge Survey (KiKS)	This will measure objective kidney disease knowledge, based on a score of 0-100, where 0 means poor level of kidney knowledge, and 100 means good level of kidney knowledge. The KiKS was developed by Dr. Wright.	Length of doctor's appointment, e.g., 1-2 hours
Primary	Level of perceived understanding of CKD as measured by the Perceived Kidney Knowledge Survey (PiKS)	This will measure subjective kidney knowledge. Score range is 1-4, where 1 is low level of perceived kidney knowledge, and 4 is high level of perceived kidney knowledge. The PiKS was developed by Dr. Wright.	Length of doctor's appointment, e.g., 1-2 hours
Secondary	Level of positive perception of patient-provider communication as measured by the Patient Communication Assessment Tool (CAT)	This assesses the quality of physician to patient and physician's staff to patient communication. Score range is 1-5, where 1 means negative perception of communication and 5 means positive perception of communication.	Length of doctor's appointment, e.g., 1-2 hours
Secondary	Level of mental anxiety/stress related to condition as measured by the adapted NDBCSS scale	The 19-item NDBCSS (Newly Diagnosed Breast Cancer Stress Scale) is adapted to form the 21-item scale in the patient survey to measure stress associated with CKD. The score range is 1-4, where 1 means high level of stress associated with CKD and 4 means low level of stress associated with CKD.	Length of doctor's appointment, e.g., 1-2 hours
Secondary	Level of energy/fatigue and emotional well-being as measured by the SF-36 mental health component	The SF-36 mental health component is a 9-item scale that measures energy/fatigue and emotional well-being in the past 4 weeks.Score range is 0-100, where 0 means poor emotional well-being and low energy and 100 means good emotional well-being and high energy.	4 weeks